SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Sponsored by Seoul National University Hospital
About this trial
Last updated a year ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 5 months ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* first-degree relatives of Inflammatory Bowel Disease patients
* patients who are diagnosed with autoimmune diseases
* patients with functional gastrointestinal disorders who are ASCA-positive
Exclusion Criteria
* Patients with symptoms such as a 10% weight loss within 3 months, abdominal pain, hematochezia, or diarrhea will undergo colonoscopy, and those diagnosed with Inflammatory Bowel Disease will be excluded.
* Treatment history of Diabetes Mellitus, Irritable Bowel Syndrome, or colon cancer.
